Sign in
Taking people in United StatesNo phase

Wearable heat-based device to check shunt fluid flow in hydrocephalus

Tests a wireless device measuring shunt flow in people with hydrocephalus.

Key facts

Who runs it
Rhaeos, Inc.
Where
Chicago and Richmond, United StatesSee the 2 sites
Trial code
Registry title
Assessment of CSF Shunt Flow During Activities of Daily Living and Sleep With a Thermal Measurement Device
Status
Recruiting
People taking part
28 people, planned
Started
10 Nov 2025
Expected to end
30 Jun 2027
Type of study
Interventional, 2 groups
Treatments tested
  • wireless thermal anisotropy measurement device
Record updated
25 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for young people with hydrocephalus who have a shunt in the brain to drain fluid. It tests a skin device that measures shunt flow at home, during daily life and sleep.

Age
At least 5 years old and younger than 22 years (the record also lists a minimum age of 2 Years).
Sex
All sexes can join.
Disease stage
People with an existing ventricular CSF shunt that can be felt under intact skin where it crosses the collarbone. Group A: stable brain fluid spaces, no shunt repair in the past 2 years and no signs of shunt failure now. Group B: a shunt repair in the past 7 days and likely to leave hospital within 4 days of joining.
Earlier treatment
Must already have a ventricular CSF shunt. Group A: no shunt revision in the previous 2 years. Group B: a shunt revision in the previous 7 days.

Main reasons for not taking part

  • The shunt cannot be felt, or it lies deeper than 4 mm on ultrasound where the device goes.
  • An open wound or swelling in the area where the device is placed.
  • A past serious skin reaction to silicone-based adhesives.
  • The person or caretaker is unlikely to take reliable measurements or place the device at home without help.
  • Being in another study that could affect the data, or having joined this study before.

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Existing ventricular CSF shunt
  • (Cohort A) A history of stable ventricular size, no shunt revision in the previous 2 years, and no current symptoms of shunt failure
  • (Cohort B) A shunt revision in the previous 7 days and the investigator judges that the patient will likely be discharged within 4 days of the enrollment date
  • Region of intact skin overlying an unambiguously identifiable palpable chronically indwelling ventricular shunt which crosses the clavicle and is appropriate in size for application of the study device
  • Signed informed consent by subject or a parent, legal guardian, health care agent, or surrogate decision maker (according to local statutes)
  • Subject is at least 5 years old but < 22 years old

Who cannot take part

  • Use of the study device would interfere with standard patient care, or emergency surgery that cannot be delayed, or participation in the study will interfere with, or be detrimental to, administration of optimal healthcare to the subject
  • Prior enrollment in this study
  • Subject-reported history of serious adverse skin reactions to silicone-based adhesives
  • Shunt is not palpable or depth of shunt where the device will be placed is greater than 4 mm per ultrasound evaluation
  • Presence of an interfering open wound or edema in the study device measurement region
  • Investigator judges that the subject is likely to be lost to follow-up due to unavailability or clinical outcome being unobtainable
  • Investigator judges that the subject is unlikely to successfully take reliable measurements at home
  • Investigator judges that the subject/subject's caretaker would not be able to successfully place the device without assistance
  • Participation in any other investigational procedural, pharmaceutical, and/or device study that may influence the collection of valid data under this study

Where in United States

  • Rhaeos Inc.Chicago, United StatesContact: Anna SomeraTaking people
  • Virginia Commonwealth University Medical CenterRichmond, United StatesContact: Lisa MerckTaking people

About the trial

What the trial wants to find out

This study evaluates the performance of a device for non-invasively assessing cerebrospinal fluid (CSF) shunt flow over multiple measurements performed by a study subject during activities of daily living and sleep

The 2 groups in the trial

  • No Recent RevisionTreatment being tested

    Pediatric hydrocephalus patients with an existing ventricular CSF shunt and a history of stable ventricular size, no shunt revision in the previous 2 years, and no current symptoms of shunt failure will be enrolled.

    Treatment: wireless thermal anisotropy measurement device

  • Recent RevisionTreatment being tested

    Pediatric hydrocephalus patients with an existing ventricular CSF shunt and a shunt revision in the previous 7 days who the investigator judges will likely be discharged within 4 days of the enrollment date will be enrolled.

    Treatment: wireless thermal anisotropy measurement device

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Long-Term Tracking of Fluid Dynamics in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device During Activities of Daily Living Including Sleep
Plain-language title
Wearable heat-based device to check shunt fluid flow in hydrocephalusGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
25 August 2026